Contact Information
Tel: +44 1789 451822
Fax: +44 1789 450682
Email: info@heartrhythmcongress.org.uk
Heart Rhythm Congress
PO Box 3697
Diary of Events
|
Date & Time
|
What's On
|
Details
|
Location
|
|---|---|---|---|
|
Tuesday 4th October 19:00 - 00:00 |
Gala Dinner |
We invite you to join friends and colleagues at the HRC Gala Dinner. Complimentary pre-dinner drinks will launch the evening, followed by a sumptious 3-course meal and the winners of the Young Investigators Competition will be announced. Tables seat 10 guests. Tickets available from Industry or can be purchased individually from Sara Newbold - sara@heartrhythmcongress.org.uk 01789 451831 Individual ticket prices: Consultants & Industry £75
|
Kings Suite |
|
Monday 3rd October - Wednesday 5th October |
BARD® EP Mini Case Review Sessions |
These 30minute EP Teaching Sessions are to be held during breaktimes & lunchtimes on the BARD® EP stand. A Consultant Electrophysiologist will present a real life EP case. Participants will be encouraged to interact with the case, including making measurements of intervals. |
Monarch Suite Exhibition |
|
Monday 3rd October 13:30 - 17:15 |
Hands-On Session
|
This session will give attendees the opportunity to get practical experience with programmers and devices from participating device companies. Technical experts will be on hand to demonstrate and teach on all aspects of device setup and programming. The session will run all afternoon so that you can drop in and out at your convenience. |
Arden Room |
|
Tuesday 4th October 12:15 - 13:30 |
RECCOVVER Meeting
|
An invitation is extended to all UK-based cardiologists who are interested in the role of implanted devices for the management of heart failure to discuss a research proposal called RECCOVVER (Randomised trial of Early Combined CRT, Volume status assessment and Ventricular Rhythm therapy). The study aims to randomise a large number (3000) and broad range of patients recovering from an episode of worsening heart failure to either an implanted device prior to or soon after discharge (with CRT-D being the preferred option) compared to a delayed and selective approach only after optimisation of medical therapy as advised in European Society of Cardiology guidelines. The study is designed to be simple and practical. It is not yet funded. However, without enthusiasm and support from you this is unlikely to happen. We hope to enagage all centres implanting CRT-D in the UK in the study. By doing so, we believe this might require only two implanted devices per centre per month for study purposes over a 2-3 year period. Professor Cleland will give a short presentation in te Lancaster room on Tuesday 4th October from 12:15 - 13:30. All interested parties welcome, especially those wishing to contribute to protocol development and to lead the effort. |
Lancaster Room |
HOME